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Abstract Various substituted 2-(5-substituted-2-oxoin-
dolin-3-ylidene)-N-substituted hydrazine carbothioamide
4a–g and 2-(5-substituted-1-(4-substituted benzyl)-2-oxo-
indolin-3-ylidene)-N-substituted hydrazine carbothioamide
5a–k were synthesized. The compounds were evaluated for
their cytostatic activity against human Molt4/C8 and CEM
T-lymphocytes as well as murine L1210 leukemia cells.
Several of these compounds were endowed with low
micromolar 50%-inhibitory concentration (IC50) values,
and some were virtually equally potent as melphalan. The
most potent inhibitors against the murine leukemia cells
were also most inhibitory against human T-lymphocyte
tumor cells. 2-(5-fluoro-1-(4-fluorobenzyl)-2-oxoindolin-3-
ylidene)-N-p-tolylhydrazine carbothioamide (5b) emerged
as the most potent cytostatic compound among the tested
compounds. The encouraging cytostatic data provide an
adequate rationale for further modification of these
molecular scaffolds.
Keywords 2,3-dioxo-2,3-dihydroindole 
Thiosemicarbazones  Cytostatic assays
Introduction
Isatin has been known for about 150 years and has recently
been found, like 2,3-dioxo-indoles and endogenous poly-
functional heterocyclic compounds, to exhibit biological
activity in mammals (Somogyi, 2001). Isatin is also a
synthetically versatile substrate that can be used to prepare
a large variety of heterocyclic compounds, such as indoles
and quinolines, and as a raw material for drug synthesis
(Silva et al., 2001). Schiff bases and Mannich bases of
isatin are known to possess a wide range of pharmaco-
logical properties including antibacterial (Pandeya et al.,
1998; Sarangapani and Reddy, 1994; Varma and Nobles,
1975), anticonvulsant (Sridhar et al., 2002; Varma et al.,
2004), anti-HIV (Pandeya et al., 1998 1999a, b 2000;
Sriram et al., 2000), antifungal (Pandeya et al., 1999a, b),
antiviral (Singh et al., 1983), and anticancer activity (Karki
et al., 2004, 2007, 2009).
Thiosemicarbazones of various aldehydes and ketones
occupy a special place among organic ligands, since they
contain various donor atoms and are able to change density
depending on the starting reagents and their reaction con-
ditions. Isatin-3-thiosemicarbazones (1H-indole-2,3-dioxo-
3-thiosemicarbazones) have been studied extensively due
to their important biological activities (Karki et al., 2009),
since 1-methylisatin-3-thiosemicarbazone (Marboran) was
found to be active in the treatment of smallpox. Previous
studies by our group have revealed the promising cytotoxic
properties of various 2,3-dioxo-2,3-dihydroindole thio-
semicarbazones (Karki et al., 2009). Therefore, we have
performed the synthesis of new N-4-aryl thiosemicarba-
zone derivatives of substituted 2,3-dioxo-2,3-dihydroin-
doles and studied their antiproliferative activity against
human Molt 4/C8 and CEM T-lymphocytes as well as
murine L1210 leukemia cells.
S. S. Karki (&)  A. Kulkarni  N. Teraiya
Department of Pharmaceutical Chemistry, KLE University’s
College of Pharmacy, Rajajinagar, Bangalore 560010,
Karnataka, India
e-mail: subhasskarki@gmail.com
E. De Clercq  J. Balzarini
Rega Institute for Medical Research, Katholieke Universiteit
Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
123
Med Chem Res (2011) 20:1229–1234
DOI 10.1007/s00044-010-9458-3
MEDICINAL
CHEMISTRY
RESEARCH
Author's personal copy
Experimental
Chemistry
All reagents were obtained from Sigma-Aldrich Mumbai,
and Loba Chemie, Mumbai. All the solvents used in these
studies were dried and distilled before use. Melting points
were recorded on a Veego VMP-PM digital melting point
apparatus, and are uncorrected. FT-IR spectras were
recorded on Shimadzu 8400 S, FT-IR. 1H NMR spectra
were recorded on 300 MHz JEOL NMR Spectrophotome-
ter in CDCl3 and DMSO-d6. All spectras were obtained
from Pune University, Maharashtra, India.
Synthesis of the intermediate indoline-2,3-diones
The synthesis of the intermediate indoline-2,3-diones was
accomplished using a literature methodology (Marvel and
Heirs, 1941), and a previously reported procedure was used
to convert these compounds to the corresponding 1-benzyl-
indoline-2,3-diones (Azizian et al., 2003). The N-4-aryl-
thiosemicarbazides required in the preparation of 4a–g and
5a–k were prepared by a literature methodology (Sen and
Sengupta, 1962; Lieber et al., 1957).
General procedure for the synthesis of 4a–g and 5a–k
A mixture of the indoline-2,3-diones (2)/1-benzylindoline-
2,3-dihydroindole (3) (0.005 mol), N-(4-substituted aryl)-
thiosemicarbazides (0.005 mol), acetic acid (0.5–1.0 ml),
and ethanol (100 ml) was heated under reflux until the
reaction was completed (approximately 4 h). Approxi-
mately half of the ethanol was removed in vacuo, and the
solution was left overnight at room temperature. The solid
which precipitated was collected by filtration, washed with
cold ethanol, and recrystallized from ethanol:chloroform
(9:1) to give compounds 4a–g and 5a–k, respectively.
2-(5-chloro-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (4a)
Yield 69%. mp 260–261C. FT-IR vmax cm-1 (KBr): 1129,
1289, 1686, 3061, 3143, 3226, 3246. 1H-NMR d: 6.9–7.8
(m, 7H, Ar–H), 10.94 (s, 1H, CO–NH), 11.38 (s, 1H, N–
NH), 12.66 (s, 1H, NH).
2-(5-bromo-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (4b)
Yield 86%. mp 255–258C. FT-IR vmax cm-1 (KBr): 1131,
1295, 1672, 3019, 3113, 3220, 3250 1H-NMR d: 6.9–8.0
(m, 7H, Ar–H), 10.94 (s, 1H, CO–NH), 11.38 (s, 1H, N–
NH), 12.66 (s, 1H, NH).
2-(5-bromo-2-oxoindolin-3-ylidene)-N-p-tolylhydrazine
carbothioamide (4c)
Yield 76%. mp 255–260C. FT-IR vmax cm-1 (KBr): 1184,
1315, 1692, 3015, 3123, 3212, 3248. 1H-NMR d: 2.51 (s,
3H, CH3), 6.9–8.0 (m, 7H, Ar–H), 10.86 (s, 1H, CO–NH),
11.36 (s, 1H, N–NH), 12.59 (s, 1H, NH).
2-(5-fluoro-2-oxoindolin-3-ylidene)-N-p-tolylhydrazine
carbothioamide (4d)
Yield 78%. mp 276–280C. FT-IR vmax cm-1 (KBr): 1154,
1291, 1682, 2995, 3116, 3234, 3256. 1H-NMR d: 2.51 (s,
3H, CH3), 6.9–7.6 (m, 7H, Ar–H), 10.81 (s, 1H, CO–NH),
11.27 (s, 1H, N–NH), 12.65 (s, 1H, NH).
2-(6-chloro-5-fluoro-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (4e)
Yield 70%. mp 278–280C. FT-IR vmax cm-1 (KBr): 1164,
1317, 1698, 3019, 3133, 3213, 3243. 1H-NMR d: 6.9–7.8
(m, 6H, Ar–H), 10.2 (s, 1H, CO–NH), 11.54 (s, 1H, N–
NH), 12.63 (s, 1H, NH).
2-(6-chloro-5-fluoro-2-oxoindolin-3-ylidene)-N-p-
tolylhydrazine carbothioamide (4f)
Yield 69%. mp 267–270C. FT-IR vmax cm-1 (KBr): 1180,
1310, 1672, 3010, 3128, 3215, 3237. 1H-NMR d: 3.27 (s,
3H, CH3), 6.9–7.8 (m, 6H, Ar–H), 10.14 (s, 1H, CO–NH),
11.52 (s, 1H, N–NH), 12.62 (s, 1H, NH).
N-(4-chlorophenyl)-2-(5-fluoro-2-oxoindolin-3-
ylidene)hydrazine carbothioamide (4g)
Yield 73%. mp 290–293C. FT-IR vmax cm-1 (KBr): 1165,
1295, 1682, 3008, 3121, 3210, 3238. 1H-NMR d: 6.6–7.8
(m, 7H, Ar–H), 11.10 (s, 1H, CO–NH), 11.29 (s, 1H, N–
NH), 12.52 (s, 1H, NH).
N-(4-chlorophenyl)-2-(5-fluoro-1-(4-fluorobenzyl)-2-
oxoindolin-3-ylidene)hydrazine carbothioamide (5a)
Yield 74%. mp 197–200C. FT-IR vmax cm-1 (KBr): 1119,
1298, 1696, 3042, 3129, 3214, 3257. 1H-NMR d: 5.0 (s,
2H, CH2), 7.0–7.7 (m, 11H, Ar–H), 10.96 (s, 1H, N–NH),
12.65 (s, 1H, NH).
2-(5-fluoro-1-(4-fluorobenzyl)-2-oxoindolin-3-ylidene)-N-
p-tolylhydrazine carbothioamide (5b)
Yield 77%. mp 230–235C. FT-IR vmax cm-1 (KBr): 1126,
1287, 1681, 3054, 3143, 3212, 3251. 1H-NMR d: 2.35 (s,
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3H, CH3), 5.0 (s, 2H, CH2), 7.0–7.8 (m, 11H, Ar–H), 10.87
(s, 1H, N–NH), 12.58 (s, 1H, NH).
2-(5-chloro-1-(4-methylbenzyl)-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (5c)
Yield 86%. mp 235–239C. FT-IR vmax cm-1 (KBr): 1135,
1294, 1682, 3026, 3119, 3243, 3264. 1H-NMR d: 2.51 (s,
3H, CH3), 5.01 (s, 2H, CH2), 7.0–8.7 (m, 11H, Ar–H),
11.00 (s, 1H, N–NH), 12.58 (s, 1H, NH).
2-(5-chloro-1-(4-chlorobenzyl)-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (5d)
Yield 66%. mp 238–240C. FT-IR vmax cm-1 (KBr): 1126,
1310, 1706, 3047, 3127, 3237, 3276. 1H-NMR d: 4.96 (s,
2H, CH2), 7.0–7.9 (m, 11H, Ar–H), 10.99 (s, 1H, N–NH),
12.61 (s, 1H, NH).
2-(5-chloro-1-(4-fluorobenzyl)-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (5e)
Yield 81%. mp 230–235C. FT-IR vmax cm-1 (KBr): 1156,
1295, 1696, 3056, 3123, 3219, 3259. 1H-NMR d: 5.00 (s,
2H, CH2), 7.0–7.9 (m, 11H, Ar–H), 10.99 (s, 1H, N–NH),
12.59 (s, 1H, NH).
2-(5-bromo-1-(4-fluorobenzyl)-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (5f)
Yield 73%. mp 240–245C. FT-IR vmax cm-1 (KBr): 1134,
1287, 1685, 3014, 3161, 3206, 3245. 1H-NMR d: 5.0 (s,
2H, CH2), 7.0–8.0 (m, 11H, Ar–H), 11.0 (s, 1H, N–NH),
12.59 (s, 1H, NH).
2-(5-bromo-1-(4-fluorobenzyl)-2-oxoindolin-3-ylidene)-N-
p-tolylhydrazine carbothioamide (5g)
Yield 80%. mp 268–270C. FT-IR vmax cm-1 (KBr): 1125,
1309, 1694, 3081, 3123, 3204, 3261. 1H-NMR d: 2.37 (s,
3H, CH3), 4.95 (s, 2H, CH2), 6.9–8.0 (m, 11H, Ar–H),
10.92 (s, 1H, N–NH), 12.52 (s, 1H, NH).
2-(5-bromo-1-(4-methylbenzyl)-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (5h)
Yield 81%. mp 220–223C. FT-IR vmax cm-1 (KBr): 1124,
1295, 1710, 3004, 3153, 3210, 3251. 1H-NMR d: 2.27 (s,
3H, CH3), 4.96 (s, 2H, CH2), 7.0–8.0 (m, 11H, Ar–H),
11.00 (s, 1H, N–NH), 12.61 (s, 1H, NH).
2-(5-bromo-1-(4-chlorobenzyl)-2-oxoindolin-3-ylidene)-N-
p-tolylhydrazine carbothioamide (5i)
Yield 72%. mp 217–220C. FT-IR vmax cm-1 (KBr): 1094,
1269, 1686, 3043, 3113, 3206, 3243. 1H-NMR d: 2.51 (s,
3H, CH3), 3.35 (s, 2H, CH2), 7.0–8.0 (m, 11H, Ar–H),
10.92 (s, 1H, N–NH), 12.51 (s, 1H, NH).
2-(5-bromo-1-(4-methylbenzyl)-2-oxoindolin-3-ylidene)-N-
p-tolylhydrazine carbothioamide (5j)
Yield 79%. mp 185–190C. FT-IR vmax cm-1 (KBr): 1126,
1309, 1698, 3056, 3133, 3218, 3239. 1H-NMR d: 2.27 (s,
3H, CH3), 2.51 (s, 3H, CH3), 4.96 (s, 2H, CH2), 6.9–8.0 (m,
11H, Ar–H), 10.92 (s, 1H, N–NH), 12.54 (s, 1H, NH).
2-(5-bromo-1-(4-chlorobenzyl)-2-oxoindolin-3-ylidene)-N-
(4-chlorophenyl)hydrazine carbothioamide (5k)
Yield 76%. mp 230–233C. FT-IR vmax cm-1 (KBr): 1120,
1296, 1684, 3046, 3135, 3216, 3247. 1H-NMR d: 4.94 (s,
2H, CH2), 6.4–7.7 (m, 11H, Ar–H), 11.29 (s, 1H, N–NH),
12.52 (s, 1H, NH).
Cytostatic assays
The methodology for undertaking the antiproliferative
assays has been published previously (Baraldi et al., 2004).
In brief, varying concentrations of the compounds (5-fold
dilutions) were incubated at 37C for 72 h (Molt4/C8 and
CEM T-lymphocytes) or 48 h (L1210 cells) in 200 ll 96-
well microtiter plates, and the viable tumor cell number
was counted at the end of the incubation period using a
Coulter Counter (Coulter Electronics, Harpenden Hertz,
U.K.).
Results and discussion
Chemistry
The compounds in series 4 and 5 were prepared by the
methodologies outlined in Scheme 1. The synthesis of N-
benzyl-2,3-dioxoindole (3) was carried out by reacting
benzyl chloride with various 2,3-dioxo-indoles in the pres-
ence of potassium carbonate under reflux in DMF. The
synthesis of the 2,3-dioxo-2,3-dihydroindolo-thiosemi-
carbazones (4a–g, 5a–k) was carried out by the condensation
of various 2,3-dioxoindoles/N-arylalkyl-2,3-dioxoindoles
(2,3) with aryl thiosemicarbazide under reflux in ethanol in
the presence of catalytic amounts of glacial acetic acid. 1H
NMR spectroscopy indicated that the compounds exist as
Med Chem Res (2011) 20:1229–1234 1231
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single isomers in solution. The compounds adopted the
Z conformation (Karki et al., 2009).
Biological activity
The compounds were evaluated for their cytostatic activity
against human Molt4/C8 and CEM T-lymphocytes as well
as murine L1210 leukemia cells. The data are summarized
in Table 1.
Several compounds (4c–d and 5b–c) showed IC50 val-
ues in the low micromolar range (1–10 lM). Molt4/C8
cells were slightly more sensitive to the cytostatic activity
of the compounds in both series 4 and 5 than CEM or
L1210 cells.
NH2
R1
R2
NH
O
O
R1
R2
N
O
O
R1
R2
R3
NH
O
N
NH
S
NH
R1
R2
R4
N
O
N
NH
SNH
R1
R2
R4
R3
1
3
2
iii
iii
iii
4a-g
5a-k
Scheme 1 Synthesis of compounds 4a–g and 5a–k. The reagents used are as follows: i CCl3CH(OH)2/H2SO4/Na2SO4; ii R3-C6H4CH2Cl/
K2CO3/DMF; iii R4-C6H4NHCSNHNH2. The nature of the R1, R2, R3, and R4 substituents are presented in Table 1
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There was, in general, a strong correlation between the
three tumor cell lines regarding the cytostatic activities of
the compounds. The most potent inhibitors of murine
L1210 cell proliferation (i.e., 4c and 4d, and 5b and 5c)
were also most inhibitory to human T-lymphocyte CEM
and Molt4/C8 cell proliferation. Also, the scaffold of the
most potent cytostatic compound in the 4 series (4d) was
most inhibitory in the 5 series (5b). In the majority of
cases, introduction of the R3-benzyl substituent in the thi-
osemicarbazone derivative series 5 often led to (slightly)
less potent inhibitors of tumor cell proliferation. In a
number of cases, replacement of the chloro at R4 by a
methyl resulted in a marked potentiation of the cytostatic
activity (compare 4b with 4c; 4g with 4d; 5a with 5b)
(Table 1). In the 5 series of compounds, replacement of the
chlorine atom at R1 by a bromine often resulted in a
decreased activity; i.e., compare 5c with 5h; 5d with 5k;
and 5e with 5f.
Conclusion
Two series of derivatives of 2,3-dioxo-2,3-dihydroindol-
(N-4-substituted aryl)-thiosemicarbazones were prepared in
good yields. All compounds were evaluated for cytostatic
activity against human Molt4/C8 and CEM T-lymphocytes
and murine L1210 leukemia cells. The compounds 4c, 4d,
5b, and 5c had IC50 values in the low micromolar range
(1–10 lM). Among the tested compounds, 5b and 4d had
antiproliferative potencies that were close to those obtained
for melphalan and should be the basis for further synthesis
of more potent cytostatic agents.
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